Table 5 Measures of stroke* risk assessment for selected bilateral CCA phenotypes in this study and for reported Framingham scores ^†

IMT and diameter both large, bilaterally

Men (51)

0.44

0.81

2.28 (1.84-2.84)

0.69 (0.59-0.81)

Women (42)

0.64

0.79

3.10 (2.56-3.76)

0.46 (0.33-0.63)

IMT large bilaterally, regardless of diameter

Men (73)

0.63

0.67

1.92 (1.66-2.22)

0.55 (0.43-0.69)

Women (52)

0.79

0.65

2.23(1.96-2.55)

0.33 (0.21-0.52)

Diameter large bilaterally, regardless of IMT

Men (75)

0.65

0.63

1.74 (1.51-2.00)

0.56 (0.43-0.71)

Women (49)

0.74

0.61

1.93 (1.66-2.23)

0.42 (0.28-0.63)

IMT and diameter both large on same side, unilaterally or bilaterally

Men (83)

0.72

0.57

1.68 (1.49-1.90)

0.49 (0.36-0.65)

Women (53)

0.80

0.56

1.84 (1.62-2.08)

0.35 (0.21-0.57)

Large IMT, unilaterally or bilaterally, regardless of diameter

Men (100)

0.87

0.35

1.33 (1.23-1.43)

0.38 (0.24-0.61)

Women (61)

0.92

0.33

1.38 (1.28-1.48)

0.23 (0.10-0.53)

Large diameter, unilaterally or bilaterally, regardless of IMT

Men (91)

0.79

0.39

1.30 (1.18-1.43)

0.54 (0.37-0.77)

Women (56)

0.85

0.40

1.41 (1.27-1.56)

0.38 (0.22-0.68)

Large IMT bilaterally and/or large diameter bilaterally

Men (97)

0.84

0.49

1.65 (1.51-1.80)

0.32 (0.21-0.49)

Women (59)

0.89

0.47

1.68 (1.54-1.83)

0.23 (0.11-0.46)

Framingham score: CVD ^†

Men

0.72

0.81

3.85 (3.34-4.44)

0.34 (0.25-0.48)

Women

0.62

0.81

3.23 (2.70-3.86)

0.47 (0.36-0.62)

Cerebrovascular score ^†

Men

0.76

0.81

4.1 (3.60-4.68)

0.29 (0.20-0.42)

Women

0.64

0.81

3.36 (2.83-3.99)

0.44 (0.33-0.59)